These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22326841)

  • 1. The DRD2/ANKK1 gene is associated with response to add-on dextromethorphan treatment in bipolar disorder.
    Lee SY; Chen SL; Chang YH; Chen SH; Chu CH; Huang SY; Tzeng NS; Wang CL; Lee IH; Yeh TL; Yang YK; Lu RB
    J Affect Disord; 2012 May; 138(3):295-300. PubMed ID: 22326841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotype variant associated with add-on memantine in bipolar II disorder.
    Lee SY; Chen SL; Chang YH; Chen SH; Chu CH; Huang SY; Tzeng NS; Wang CL; Wang LJ; Lee IH; Yeh TL; Yang YK; Hong JS; Lu RB
    Int J Neuropsychopharmacol; 2014 Feb; 17(2):189-97. PubMed ID: 24103632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The COMT Val158Met Polymorphism Is Associated With Response to Add-on Dextromethorphan Treatment in Bipolar Disorder.
    Lee SY; Chen SL; Wang TY; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Chen KC; Yang YK; Lu RB
    J Clin Psychopharmacol; 2017 Feb; 37(1):94-98. PubMed ID: 27930497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of add-on low-dose dextromethorphan plus valproic acid in bipolar disorder.
    Chen SL; Lee SY; Chang YH; Chen PS; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1753-9. PubMed ID: 25262178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of add-on low-dose memantine on cytokine levels in bipolar II depression: a 12-week double-blind, randomized controlled trial.
    Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Wang TY; Yeh TL; Yang YK; Hong JS; Lu RB
    J Clin Psychopharmacol; 2014 Jun; 34(3):337-43. PubMed ID: 24717258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder.
    Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang YS; Wang LJ; Lee IH; Yeh TL; Yang YK; Lu RB; Hong JS
    J Psychiatr Res; 2013 Oct; 47(10):1343-8. PubMed ID: 23870798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALDH2 polymorphism, associated with attenuating negative symptoms in patients with schizophrenia treated with add-on dextromethorphan.
    Lee SY; Chen SL; Chang YH; Chen PS; Huang SY; Tzeng NS; Wang LJ; Lee IH; Wang TY; Chen KC; Yang YK; Hong JS; Lu RB
    J Psychiatr Res; 2015 Oct; 69():50-6. PubMed ID: 26343594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ALDH2 and DRD2/ANKK1 genes interacted in bipolar II but not bipolar I disorder.
    Lee SY; Chen SL; Chang YH; Chen SH; Chu CH; Huang SY; Tzeng NS; Wang CL; Lee IH; Yeh TL; Yang YK; Lu RB
    Pharmacogenet Genomics; 2010 Aug; 20(8):500-6. PubMed ID: 20577142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between DRD2/ANKK1 TaqIA Polymorphism and Susceptibility with Tourette Syndrome: A Meta-Analysis.
    Yuan A; Su L; Yu S; Li C; Yu T; Sun J
    PLoS One; 2015; 10(6):e0131060. PubMed ID: 26110876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between
    Ramos-Lopez O; Mejia-Godoy R; Frías-Delgadillo KJ; Torres-Valadez R; Flores-García A; Sánchez-Enríquez S; Aguiar-García P; Martínez-López E; Zepeda-Carrillo EA
    Nutrients; 2019 Nov; 11(12):. PubMed ID: 31766642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High frequency of the DRD2/ANKK1 A1 allele in Mexican Native Amerindians and Mestizos and its association with alcohol consumption.
    Panduro A; Ramos-Lopez O; Campollo O; Zepeda-Carrillo EA; Gonzalez-Aldaco K; Torres-Valadez R; Roman S
    Drug Alcohol Depend; 2017 Mar; 172():66-72. PubMed ID: 28152448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction between BDNF and DRD2 in bipolar II disorder but not in bipolar I disorder.
    Huang CC; Chang YH; Lee SY; Chen SL; Chen SH; Chu CH; Huang SY; Tzeng NS; Lee IH; Yeh TL; Yang YK; Lu RB
    Am J Med Genet B Neuropsychiatr Genet; 2012 Jul; 159B(5):501-7. PubMed ID: 22514151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A DRD2 and ANKK1 haplotype is associated with nicotine dependence.
    Voisey J; Swagell CD; Hughes IP; van Daal A; Noble EP; Lawford BR; Young RM; Morris CP
    Psychiatry Res; 2012 Apr; 196(2-3):285-9. PubMed ID: 22382052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients.
    Shen YC; Chen SF; Chen CH; Lin CC; Chen SJ; Chen YJ; Luu SU
    J Psychiatr Res; 2009 Mar; 43(6):600-6. PubMed ID: 18926547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS; Konarski JZ; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DRD2/ANKK1 TaqI A1 polymorphism associates with overconsumption of unhealthy foods and biochemical abnormalities in a Mexican population.
    Rivera-Iñiguez I; Panduro A; Ramos-Lopez O; Villaseñor-Bayardo SJ; Roman S
    Eat Weight Disord; 2019 Oct; 24(5):835-844. PubMed ID: 30353454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ANKK1/DRD2 gene TaqIA polymorphism (rs1800497) is associated with the severity of extrapyramidal side effects of haloperidol treatment in CYP2D6 extensive metabolizers with schizophrenia spectrum disorders.
    Kibitov AA; Kiryanova EM; Salnikova LI; Bure IV; Shmukler AB; Kibitov AO
    Drug Metab Pers Ther; 2023 Jun; 38(2):133-142. PubMed ID: 36437548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse.
    Spellicy CJ; Kosten TR; Hamon SC; Harding MJ; Nielsen DA
    Pharmacogenet Genomics; 2013 Jul; 23(7):333-40. PubMed ID: 23635803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.